Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Polymerase Chain Reaction Molecular Diagnostics Market Expected To Expand Between 2025 And 2029?
The polymerase chain reaction molecular diagnostics market size has seen substantial growth in recent periods. It is projected to expand from $8.97 billion in 2024 to $9.75 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.6%. Historically, this expansion was driven by several factors, including the growing need for prompt disease identification, the rising occurrence of contagious illnesses, heightened understanding of hereditary conditions, the greater uptake of on-site diagnostic tests, and the escalating frequency of long-term health issues.
The polymerase chain reaction molecular diagnostics market size is projected for substantial expansion in the coming years. This market is anticipated to reach $13.54 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.6%. Several factors are expected to fuel this growth during the forecast period, including the increasing incidence of cancer, the escalating need for personalized medicine, boosted investments in molecular diagnostics, the expanding requirement for swift diagnostic tests, and the rising interest in non-invasive prenatal testing. Significant trends characterizing this period involve progress in diagnostic technologies, the creation of point-of-care polymerase chain reaction systems, advancements in multiplex polymerase chain reaction, the convergence of polymerase chain reaction with microfluidics, and enhancements in digital polymerase chain reaction platforms.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24383&type=smp
What Are The Top Growth Drivers Impacting The Polymerase Chain Reaction Molecular Diagnostics Market Outlook?
The increasing occurrence of infectious ailments is anticipated to drive the expansion of the polymerase chain reaction molecular diagnostics market in the future. Infectious diseases are conditions resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which possess the capability to transmit either directly or indirectly between individuals. The widespread nature of infectious diseases is escalating due to the appearance of antibiotic-resistant pathogens, which prove more challenging to manage and contain, thus resulting in extended sickness, elevated healthcare expenditures, and significant public health dangers. Polymerase chain reaction (PCR) molecular diagnostics improve the handling of infectious diseases through the provision of quick, precise identification of pathogens at their genetic level, facilitating prompt diagnosis and focused therapeutic approaches. This leads to better healthcare results by allowing for prompt medical actions, curbing the transmission of infections, and refining patient treatment. As an illustration, in November 2023, data from the Department of Health and Human Services, a US-based government department, indicated that newly reported chronic hepatitis B (a viral infection that affects the liver and can lead to both acute and chronic disease) instances increased by 11% in 2022 compared to 2021. Consequently, the growing occurrence of infectious diseases is fueling the expansion of the polymerase chain reaction molecular diagnostics market.
What Are The Major Segment Categories Driving The Polymerase Chain Reaction Molecular Diagnostics Market Growth?
The polymerase chain reaction molecular diagnosticsmarket covered in this report is segmented –
1) By Product Type: Instrument; Reagents And Consumables; Software
2) By Technology: Real-Time Polymerase Chain Reaction; Digital Polymerase Chain Reaction; Conventional Polymerase Chain Reaction
3) By Sample Type: Blood Samples; Saliva Samples; Tissue Samples; Urine Samples
4) By Application: Infectious Disease Testing; Oncology Testing; Other Applications
5) By End-User: Hospitals; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Instrument: Standard Polymerase Chain Reaction Systems; Digital Polymerase Chain Reaction Systems; Real-Time Polymerase Chain Reaction Systems
2) By Reagents And Consumables: Polymerase Chain Reaction Kits; Polymerase Chain Reaction Enzymes; Polymerase Chain Reaction Primers and Probes; Polymerase Chain Reaction Master Mix
3) By Software: Polymerase Chain Reaction Analysis Software; Data Management Software
What Are The Major Trends Driving The Growth Of The Polymerase Chain Reaction Molecular Diagnostics Market?
Leading companies in the polymerase chain reaction molecular diagnostics market are concentrating on developing technologically advanced solutions, such as benchtop instruments, to boost testing efficiency and accessibility. Benchtop instruments are compact, laboratory-grade devices designed to fit on a workbench or table, employed for scientific, medical, or industrial testing and analysis. For instance, in September 2024, QIAGEN N.V., a Germany-based biotechnology company, unveiled the QIAcuityDx Digital PCR System for clinical testing in oncology. This system offers fully automated, walk-away processing that integrates partitioning, thermocycling, and imaging into a single instrument, providing absolute quantification of deoxyribonucleic acid and ribonucleic acid with results in about two hours and minimal hands-on time. The system supports up to five detection channels for multiplexing and continuous nanoplate loading, offering both validated and flexible research modes, thereby making it adaptable for diverse clinical and laboratory needs.
Who Are The Core Companies Influencing The Polymerase Chain Reaction Molecular Diagnostics Market Landscape?
Major companies operating in the polymerase chain reaction molecular diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Grifols S.A., Illumina Inc., Endress + Hauser AG, bioMereieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, Zymo Research Corporation.
Download The Full Report For Exclusive Market Findings:
Which Region Is Expected To Witness The Fastest Growth In The Polymerase Chain Reaction Molecular Diagnostics Market?
North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Polymerase Chain Reaction Molecular Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=24383&type=smp
Browse Through More Reports Similar to the Global Polymerase Chain Reaction Molecular Diagnostics Market 2025, By The Business Research Company
Polymerase Chain Reactions Devices Reagents And Uses Global Market Report 2025
Colorectal Cancer Molecular Diagnostics Global Market Report 2025
Molecular Biology Enzymes And Kits And Reagents Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model